<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cui M</submitter><funding>Chinese Academy of Medical Sciences</funding><funding>National Natural Science Foundation of China</funding><pagination>613530</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8024581</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>Traditionally, immunoglobulin (Ig) was believed to be produced by only B-lineage cells. However, increasing evidence has revealed a high level of Ig expression in cancer cells, and this Ig is named cancer-derived Ig. Further studies have shown that cancer-derived Ig shares identical basic structures with B cell-derived Ig but exhibits several distinct characteristics, including restricted variable region sequences and aberrant glycosylation. In contrast to B cell-derived Ig, which functions as an antibody in the humoral immune response, cancer-derived Ig exerts profound protumorigenic effects &lt;i>via&lt;/i> multiple mechanisms, including promoting the malignant behaviors of cancer cells, mediating tumor immune escape, inducing inflammation, and activating the aggregation of platelets. Importan</pubmed_abstract><journal>Frontiers in immunology</journal><pubmed_title>Immunoglobulin Expression in Cancer Cells and Its Critical Roles in Tumorigenesis.</pubmed_title><pmcid>PMC8024581</pmcid><funding_grant_id>2018PT32014</funding_grant_id><funding_grant_id>81872501, 81673023, 82030044, 91642206</funding_grant_id><pubmed_authors>Cui M</pubmed_authors><pubmed_authors>Qiu X</pubmed_authors><pubmed_authors>Huang J</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Liao Q</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Immunoglobulin Expression in Cancer Cells and Its Critical Roles in Tumorigenesis.</name><description>Traditionally, immunoglobulin (Ig) was believed to be produced by only B-lineage cells. However, increasing evidence has revealed a high level of Ig expression in cancer cells, and this Ig is named cancer-derived Ig. Further studies have shown that cancer-derived Ig shares identical basic structures with B cell-derived Ig but exhibits several distinct characteristics, including restricted variable region sequences and aberrant glycosylation. In contrast to B cell-derived Ig, which functions as an antibody in the humoral immune response, cancer-derived Ig exerts profound protumorigenic effects &lt;i>via&lt;/i> multiple mechanisms, including promoting the malignant behaviors of cancer cells, mediating tumor immune escape, inducing inflammation, and activating the aggregation of platelets. Importan</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-05-29T20:03:14.781Z</modification><creation>2025-05-29T20:03:14.781Z</creation></dates><accession>S-EPMC8024581</accession><cross_references><pubmed>33841396</pubmed><doi>10.3389/fimmu.2021.613530</doi></cross_references></HashMap>